STAT

STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more

STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and moreWorldPing

UniQure has submitted its Huntington’s gene therapy to the FDA, investors remain unenthusiastic on Novo Nordisk, and more of the latest pharma headlines in today's Pharmalittle newsletter.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news

The Verge
WorldPing
The Verge

Continuous glucose monitors are about to get more complicated

This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here.

Brief by WorldPing · Original reporting by The Verge

What remains of the last Neanderthals tell us about their demiseWorldPing
New Scientist

What remains of the last Neanderthals tell us about their demise

An isolated population of Neanderthals is shedding new light on their species’ final days.Palaeoanthropologist Ludovic Slimak takes us inside the cave where they lived and died…

Brief by WorldPing · Original reporting by New Scientist